These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease. Kelleher CC Eur J Epidemiol; 1992 May; 8 Suppl 1():79-82. PubMed ID: 1505657 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogen: its role in the hemostatic regulation in atherosclerosis. Eber B; Schumacher M Semin Thromb Hemost; 1993; 19(2):104-7. PubMed ID: 8356454 [TBL] [Abstract][Full Text] [Related]
6. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease. Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510 [TBL] [Abstract][Full Text] [Related]
7. Factors influencing the prognosis of cerebral thrombosis and infarction due to atherosclerosis. DAVID NJ; HEYMAN A J Chronic Dis; 1960 Apr; 11():394-404. PubMed ID: 13814295 [No Abstract] [Full Text] [Related]
8. [Oxidized fibrinogen and its relationship with hemostasis disturbances and endothelial dysfunction during coronary heart disease and myocardial infarction]. Ragino IuI; Baum VA; Polonskaia IaV; Baum SR; Nikitin IuP Kardiologiia; 2009; 49(9):4-8. PubMed ID: 19772496 [TBL] [Abstract][Full Text] [Related]
9. Thrombogenic risk factors for atherothrombosis. Shah PK Rev Cardiovasc Med; 2006; 7(1):10-6. PubMed ID: 16534491 [TBL] [Abstract][Full Text] [Related]
10. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058 [TBL] [Abstract][Full Text] [Related]
11. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963 [TBL] [Abstract][Full Text] [Related]
12. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?]. Jaeger BR; Labarrere CA Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394 [TBL] [Abstract][Full Text] [Related]